Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Calcinosis cutis can be classified into four subtypes: dystrophic, metastatic, idiopathic, and iatrogenic. Of these subtypes, dystrophic
calcinosis
(DC) is the most common, and is most frequently associated with connective tissue disease, particularly dermatomyositis and systemic sclerosis, and less commonly with
systemic lupus erythematosus
. However, DC associated with rheumatoid arthritis (RA) is extremely rare. In this paper, we present a Japanese woman with RA, who suffered from bilateral leg ulcers secondary to DC. To the best of our knowledge, only two cases of DC associated with RA have been reported to date. Similar to this case, the DC lesions were observed in the extremities, including the buttocks in the other two cases. Although the ulcers on her left leg were gradually epithelialized after one year, they may easily recur due to whitish abnormal underlying tissues, and a large ulcer remains on her right leg. Thus, it is important for physicians to identify DC when encountering non-healing leg ulcers associated with connective tissue diseases. J. Med. Invest. 64: 308-310, August, 2017.
...
PMID:Bilateral leg ulcers secondary to dystrophic calcinosis in a patient with rheumatoid arthritis. 2895 3
Tumoral calcinosis (TC) is a rare benign but aggressive disorder with variable response rates and high recurrence rates despite medical or surgical treatments. We herein report a case of a 28-year-old woman with underlying
systemic lupus erythematosus
(
SLE
) who developed diffuse tumoral
calcinosis
that was successfully treated by lanthanum carbonate. The formation of tumoral
calcinosis
depends on the supersaturation of calcium and phosphate. Lanthanum carbonate not only has an excellent phosphate-lowering ability but also low gastro-intestinal calcium absorption. It can be considered an effective alternative treatment for tumoral
calcinosis
if surgical treatment is not feasible.
...
PMID:Successful Treatment of Tumoral Calcinosis by Lanthanum Carbonate. 3014 73
Calcinosis cutis is a deposition of calcium salts in the skin and subcutaneous tissue which can occur in connective tissue diseases such as scleroderma, dermatomyositis, myositis and overlap syndrome, but rarely in association with
systemic lupus erythematosus
(
SLE
). It is subdivided into a localized 'circumscripta' and diffuse 'universalis'. The few reported cases of
calcinosis
in
SLE
were mainly of the circumscripta type. Calcinosis universalis is extremely rare and is usually associated with a history of chronic active
SLE
in female patients, with few proven effective treatments. We report a case of a young female patient with a long and complicated history of
SLE
. She presented with widespread pain and tenderness associated with multiple subcutaneous skin lesions. She was found to have evidence of
calcinosis
universalis on X-rays. Investigations did not reveal any associated conditions that could explain this diagnosis other than her prolonged history of
SLE
.
Lupus
2020 Oct
PMID:Calcinosis cutis universalis in a patient with systemic lupus erythematosus: a case report. 3269 83
Calcinosis cutis is a disorder of pathologic calcium deposition in the cutaneous and subcutaneous layers of skin. While common in dermatomyositis and scleroderma,
calcinosis
cutis less frequently occurs in
systemic lupus erythematosus
(
SLE
) and is infrequently described in literature. In this report, we discuss the case of a 36-year-old patient with
SLE
, presenting with vascular compromise, ulceration, and superimposed infection of her left hand as a consequence of severe
calcinosis
cutis. This report includes a review of the current literature, and highlights the importance of early detection and intervention in preventing disease complications.
...
PMID:Dystrophic Calcinosis Cutis in Systemic Lupus Erythematosus. 3271 67
<< Previous
1
2
3
4
5
6